Literature DB >> 3574619

Ganglioglioma: a correlative clinicopathological and radiological study of ten surgically treated cases with follow-up.

U P Kalyan-Raman, W C Olivero.   

Abstract

Gangliogliomas are rare benign tumors of the central nervous system containing neoplastic ganglion and low grade glial cells. In studying 10 surgically treated cases, we evaluated the clinical, pathological, radiological, and immunocytochemical features, with follow-up. Ranging from 18 to 58 years in age, 7 patients were women, and 3 were men. The most common presenting symptom was seizure. Computed tomographic scan showed a low density enhancing mass in 8 and calcification in 5. Six had minimally abnormal vascularity on angiography. Seven patients had total and 3 had subtotal resections of the tumor. The temporal lobe was the location of the tumor in 6 cases. All of the cases met the histological criteria of Russell and Rubinstein for ganglioglioma. Four patients received postoperative radiotherapy because of subtotal resection or aggressive histological makeup. On follow-up, from 2.5 to 7 years, 8 patients are alive and tumor-free, and 7 are also seizure-free. Two died after operation: one immediately and the other of a glioblastoma that developed 5 years later. Our study confirms that ganglioglioma is a distinct histological entity, anatomically localized, with characteristic clinical and radiological findings and long term survival. Aggressive histological makeup is not a definite indication of malignant potential. The definitive role of follow-up radiotherapy for this tumor needs further study. Malignant evolution is rare, but warrants follow-up.

Entities:  

Mesh:

Year:  1987        PMID: 3574619     DOI: 10.1227/00006123-198703000-00012

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  31 in total

1.  Aberrant TP53 protein accumulation in the neuronal component of ganglioglioma.

Authors:  Takao Fukushima; Yoichi Katayama; Takao Watanabe; Atsuo Yoshino; Chiaki Komine; Takakazu Yokoyama
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

Review 2.  Ganglioglioma of optic chiasma: case report and review of literature.

Authors:  Ishita Pant; Vaishali Suri; Sujata Chaturvedi; Rakesh Dua; A K Kanodia
Journal:  Childs Nerv Syst       Date:  2006-01-11       Impact factor: 1.475

3.  Intramedullary secretory gangliocytoma.

Authors:  B Azzarelli; T G Luerssen; T M Wolfe
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Anaplastic ganglioglioma of the brain stem demonstrating active neurosecretory features of neoplastic neuronal cells.

Authors:  T Hirose; S Kannuki; K Nishida; K Matsumoto; T Sano; K Hizawa
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Brainstem gangliogliomas: prognostic factors, surgical indications and functional outcomes.

Authors:  Chang-Cun Pan; Xin Chen; Cheng Xu; Wen-Hao Wu; Peng Zhang; Yu Wang; Tao Wu; Jie Tang; Xin-Ru Xiao; Zhen Wu; Jun-Ting Zhang; Li-Wei Zhang
Journal:  J Neurooncol       Date:  2016-04-25       Impact factor: 4.130

6.  Temporal lobe ganglioglioma in refractory epilepsy: CT and MR in three cases.

Authors:  M C Chamberlain; G A Press
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

Review 7.  The impact of technical adjuncts in the surgical management of cerebral hemispheric low-grade gliomas of childhood.

Authors:  M S Berger
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

8.  Spinal cord gangliogliomas: a review of 56 patients.

Authors:  George I Jallo; Diana Freed; Fred J Epstein
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

9.  Spinal ganglioneuroblastoma--complete response to chemotherapy alone.

Authors:  V Raina; R Kamble; R Tanwar; S P Singh; S Sharma
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

10.  Gangliogliomas in childhood.

Authors:  N M Smith; M M Carli; A Hanieh; B Clark; A J Bourne; R W Byard
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.